- Home
- ESPR vs PANL Comparison
ESPR vs PANL Comparison
Compare ESPR & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- PANL
- Stock Information
- Founded
- ESPR 2008
- PANL 1996
- Country
- ESPR United States
- PANL United States
- Employees
- ESPR N/A
- PANL N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- PANL Marine Transportation
- Sector
- ESPR Health Care
- PANL Consumer Discretionary
- Exchange
- ESPR Nasdaq
- PANL Nasdaq
- Market Cap
- ESPR 305.0M
- PANL 332.6M
- IPO Year
- ESPR 2013
- PANL N/A
- Fundamental
- Price
- ESPR $1.50
- PANL $5.43
- Analyst Decision
- ESPR Buy
- PANL Strong Buy
- Analyst Count
- ESPR 7
- PANL 1
- Target Price
- ESPR $6.36
- PANL N/A
- AVG Volume (30 Days)
- ESPR 4.0M
- PANL 227.2K
- Earning Date
- ESPR 03-04-2025
- PANL 03-13-2025
- Dividend Yield
- ESPR N/A
- PANL 7.37%
- EPS Growth
- ESPR N/A
- PANL 8.62
- EPS
- ESPR N/A
- PANL 0.63
- Revenue
- ESPR $332,314,000.00
- PANL $536,536,246.00
- Revenue This Year
- ESPR $5.51
- PANL $4.27
- Revenue Next Year
- ESPR $1.42
- PANL $17.15
- P/E Ratio
- ESPR N/A
- PANL $8.62
- Revenue Growth
- ESPR 185.66
- PANL 7.46
- 52 Week Low
- ESPR $1.47
- PANL $4.69
- 52 Week High
- ESPR $3.94
- PANL $8.32
- Technical
- Relative Strength Index (RSI)
- ESPR 34.95
- PANL 60.29
- Support Level
- ESPR $1.47
- PANL $4.69
- Resistance Level
- ESPR $1.61
- PANL $5.07
- Average True Range (ATR)
- ESPR 0.13
- PANL 0.17
- MACD
- ESPR -0.01
- PANL 0.02
- Stochastic Oscillator
- ESPR 7.69
- PANL 82.22
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.